U.S. flag

An official website of the United States government, Department of Justice.

Utah FY23 DC Enhancement Grant Project

Award Information

Award #
15PBJA-23-GG-04299-DGCT
Funding Category
Competitive Discretionary
Location
Congressional District
Status
Open
Funding First Awarded
2023
Total funding (to date)
$1,000,000

Description of original award (Fiscal Year 2023, $1,000,000)

The Office of Substance Use and Mental Health (OSUMH), in collaboration with the Utah Administrative Office of the Courts (AOC), is requesting funding in the amount of $1,000,000 to enhance adult drug court, fund training initiatives, and provide the opportunity to enhance and expand current services and promote racial equality. OSUMH will provide support to local substance abuse authorities to help eliminate racial inequities; funding will be allocated to support equity managers or administrators. The purpose of this project is to improve drug court functioning and improve drug court participant outcomes. The grant will fund 10 adult drug courts and one urban/rural DUI court: Cache County Adult Drug Court (rural), Box Elder Adult Drug Court (rural), San Juan Adult Drug court (rural), Iron County Adult Felony Drug Court (rural), Weber/Morgan County Adult Drug Court (urban/rural), Weber County DUI (urban), Summit County Adult Drug Court (rural), Carbon County Adult Drug Court (rural), Grand County Adult Drug Court (rural), Emery County Adult Drug Court (rural), and Uintah County Adult Drug Court (rural). All courts that requested assistance can demonstrate a specific need. In FY 2022, 1,395 were served in Utah’s drug courts. Drug courts across Utah require a minimum of 52 weeks participation, with no maximum. OSUMH will implement or expand access to clinically appropriate evidence-based practices (EBPs) for opioid use disorder (OUD) treatment, particularly the use of MAT and the use of FDA-approved medications (e.g., methadone, buprenorphine products including buprenorphine/naloxone combination formulations and buprenorphine nonproduct formulations, naltrexone products including extended-release and oral formulations, or implantable buprenorphine). The goal of MAT is full recovery, including the ability to live a self-directed life. Currently, no other federal funds are allocated to Utah’s drug courts.

Date Created: September 27, 2023